PROUDLY SUPPORTED BY:
About Event
A message from Professor
Michael Hofman, ProsTIC Director
Thank you to everyone who joined us for ProsTIC26. More than 550 delegates from 26 countries came to Melbourne for three days of presentations, case-based tumour boards and genuinely open discussion, and the calibre of people in the room reflected just how quickly this field is moving. My thanks goes to our international and Australian faculty, to the nurses and technologists who joined our pre-conference sessions, and especially to the patients, families and advocates who took part in the consumer session and opened our scientific program. Keeping their experience at the centre of the conversation is the reason we do this work.
I am grateful to our sponsors and partners, whose support made the Preceptorship possible, and allowed us to bring this community together.
The strength of a meeting like this is not only what is shared in the lecture theatre, but the ideas and collaborations that emerge when people come together. We leave ProsTIC26 with new questions to pursue, stronger international connections and a shared commitment to improving outcomes for patients with prostate cancer.
Thank you to everyone that came here to Melbourne to be a part of it.
News
- All Posts
- Blog
- News

Enjoy multi-disciplinary discussion covering nuclear medicine, radiopharmaceutical sciences, medical oncology, urology, radiation oncology, medical physics, translational sciences & industry.

Global experts unravel PSMA biology in the 2025 ProsTIC PCF Webinar, sharing the latest breakthroughs in prostate cancer research and...
Welcome to the ProsTIC Preceptorship 2026:
Case by Case Theranostics
Following the outstanding success of the 2024 Preceptorship, which welcomed over 360 delegates from 26 countries and featured expert speakers from five continents, we are excited to invite you to our ProsTIC Preceptorship 2026. This premier global meeting in Theranostics will once again bring together a diverse and multidisciplinary audience to explore the latest advancements—case by case.
Registrations will be opening soon
Subscribe for updates
Sign up to the mailing list to be the first to receive conference updates.





